Sailong Pharmaceutical Group Co.,Ltd. (SHE:002898)
China · Delayed Price · Currency is CNY 11.18
-0.10 (-0.89%)
At close: Feb 13, 2026
SHE:002898 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -69.85 | -33.15 | 9.53 | -37.31 | -23.34 | -67.22 |
Depreciation & Amortization | 33.94 | 33.94 | 33.13 | 34.06 | 32.8 | 29.29 |
Other Amortization | 0.6 | 0.6 | - | - | - | - |
Loss (Gain) From Sale of Assets | 0.9 | 0.9 | -1.06 | -0.46 | 0.01 | 0 |
Asset Writedown & Restructuring Costs | 6.59 | 6.59 | 0.01 | -0.02 | 0.18 | -31.77 |
Loss (Gain) From Sale of Investments | -0.07 | -0.07 | -7.91 | -17.09 | -8.5 | -0.02 |
Provision & Write-off of Bad Debts | 0.34 | 0.34 | -11.4 | 7.78 | - | - |
Other Operating Activities | 52.06 | 20.41 | 9.64 | 12.41 | 5.29 | 5.21 |
Change in Accounts Receivable | -36.64 | -36.64 | 60.68 | -5.02 | -10.33 | 54.11 |
Change in Inventory | -19.24 | -19.24 | -28.85 | -15.89 | 6.51 | -12.86 |
Change in Accounts Payable | -12.67 | -12.67 | -40.47 | 29.73 | 28.59 | 9.06 |
Change in Other Net Operating Assets | 2.01 | 2.01 | -0.35 | -1.63 | 0.25 | -0.19 |
Operating Cash Flow | -43.92 | -38.86 | 35.71 | 14.12 | 35.46 | 0.17 |
Operating Cash Flow Growth | - | - | 152.80% | -60.17% | 20200.01% | - |
Capital Expenditures | -32.19 | -34.67 | -30.58 | -23.94 | -31.47 | -64.06 |
Sale of Property, Plant & Equipment | 7.25 | 19.78 | 13.04 | 1.15 | 0.29 | - |
Divestitures | - | - | - | 3.24 | 7 | - |
Investment in Securities | 9.99 | 2.13 | -2.13 | - | 0.2 | -5.1 |
Other Investing Activities | 0.01 | 0.12 | 0.35 | 1.2 | 1.5 | 0.9 |
Investing Cash Flow | -14.93 | -12.64 | -19.33 | -18.35 | -22.48 | -68.26 |
Long-Term Debt Issued | - | 140.06 | 115 | 99.99 | 153.4 | 150 |
Total Debt Issued | 206.71 | 140.06 | 115 | 99.99 | 153.4 | 150 |
Long-Term Debt Repaid | - | -103.17 | -131.24 | -129.67 | -102.91 | -108.29 |
Total Debt Repaid | -151.98 | -103.17 | -131.24 | -129.67 | -102.91 | -108.29 |
Net Debt Issued (Repaid) | 54.73 | 36.89 | -16.24 | -29.68 | 50.49 | 41.71 |
Common Dividends Paid | -6.06 | -8.45 | -5.58 | -8.7 | -7.89 | -11.64 |
Other Financing Activities | -20.44 | -14.07 | 19.94 | -0.07 | -0.1 | -0.37 |
Financing Cash Flow | 28.23 | 14.37 | -1.88 | -38.45 | 42.5 | 29.7 |
Net Cash Flow | -30.62 | -37.14 | 14.5 | -42.67 | 55.48 | -38.38 |
Free Cash Flow | -76.1 | -73.53 | 5.13 | -9.82 | 3.99 | -63.88 |
Free Cash Flow Margin | -31.08% | -27.90% | 1.65% | -3.72% | 1.61% | -52.93% |
Free Cash Flow Per Share | -0.43 | -0.42 | 0.03 | -0.06 | 0.02 | -0.36 |
Cash Interest Paid | - | - | - | 0.02 | 0.1 | - |
Cash Income Tax Paid | 18.37 | 20.79 | 27.2 | 1.44 | 17.53 | 18.22 |
Levered Free Cash Flow | 20 | -57.07 | -20.16 | 2.1 | 28.18 | -42.52 |
Unlevered Free Cash Flow | 24.48 | -52.86 | -15.85 | 7.15 | 32.31 | -38.94 |
Change in Working Capital | -68.42 | -68.42 | 3.77 | 14.76 | 29.02 | 64.68 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.